Lexaria Bioscience (LEXX) Free Cash Flow (2010 - 2026)
Lexaria Bioscience (LEXX) free cash flow from Jul 31, 2010 to May 31, 2026. The TTM Lexaria Bioscience (LEXX) free cash flow is -$7.46M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Lexaria Bioscience (LEXX) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -23.57% |
| 3 Years TTM | +20.25% |
| 5 Years TTM | +15.75% |
| 10 Years TTM | +22.50% |
| All Time TTM | +28.54% |
Annual Free Cash Flow change of Lexaria Bioscience (LEXX)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$3.84M | -63.32% |
| 2025 | -$10M | +109.40% |
| 2024 | -$5M | -15.40% |
| 2023 | -$5.91M | +21.11% |
| 2022 | -$4.88M | +22.31% |
| 2021 | -$3.99M | +50.00% |
| 2020 | -$2.66M | -27.32% |
| 2019 | -$3.66M | +45.24% |
| 2018 | -$2.52M | +62.58% |
| 2017 | -$1.55M | +134.85% |
| 2016 | -$660K | -56.00% |
| 2015 | -$1.50M | +188.46% |
| 2014 | -$520K | -262.50% |
| 2013 | $320K | +128.57% |
| 2012 | $140K | -170.00% |
| 2011 | -$200K | -39.39% |
| 2010 | -$330K | N/A |
Comparison Lexaria Bioscience (LEXX) five years free cash flow CAGR with competitors
Lexaria Bioscience (LEXX) five years free cash flow CAGR is 21.42%.